FindTrial
Sign In

Phase 3 study of cetirizine dry syrup in children suffering from perennial allergic rhinitis (Comparative study)

Phase 3 study of cetirizine dry syrup in children suffering from perennial allergic rhinitis (Comparative study)

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220122
Enrollment
286
Registered
2005-09-13
Start date
2005-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial Allergic Rhinitis

Interventions

investigational material(s) Generic name etc : Cetirizine INN of investigational material : Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational mat

Sponsors

GlaxoSmithKline K.K.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: 3 to 14, Children with perennial allergic rhinitis, Patients eligible for evaluation of nasal symptom, etc.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change in the total nasal symptom score, safety, etc—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026